Xvivo Perfusion AB (OSTO:XVIVO) 3-Year Dividend Growth Rate : 0.00% (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Xvivo Perfusion AB 3-Year Dividend Growth Rate?

Xvivo Perfusion AB's Dividends per Share for the three months ended in Mar. 2024 was kr0.00.

The historical rank and industry rank for Xvivo Perfusion AB's 3-Year Dividend Growth Rate or its related term are showing as below:

OSTO:XVIVO's 3-Year Dividend Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 11.9
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Xvivo Perfusion AB's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Xvivo Perfusion AB's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Xvivo Perfusion AB's 3-Year Dividend Growth Rate

For the Medical Devices subindustry, Xvivo Perfusion AB's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xvivo Perfusion AB's 3-Year Dividend Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xvivo Perfusion AB's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Xvivo Perfusion AB's 3-Year Dividend Growth Rate falls into.

Xvivo Perfusion AB 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Xvivo Perfusion AB (OSTO:XVIVO) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Xvivo Perfusion AB's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2024 )	/	EPS without NRI (Q: Mar. 2024 )
	=	0	/	0.72
	=	0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xvivo Perfusion AB 3-Year Dividend Growth Rate Related Terms>

Xvivo Perfusion AB (OSTO:XVIVO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (OSTO:XVIVO) » Definitions » 3-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

XVIPF:USA 3XV:Germany

Address

Massans gata 10, P.O. Box 53015, Gothenburg, SWE, SE-400 14

Website

https://www.xvivoperfusion.com

Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.

Xvivo Perfusion AB (OSTO:XVIVO) Headlines

No Headlines